Search Results

Feb 10, 2026, 09:00 ET AsymBio Establishes Integrated Technology Platforms Spanning the Full Biopharmaceutical Development Lifecycle

lifecycle, and comprising the Physicochemical Platform, Mass Spectrometry Platform, and Bioassay Platform.AsymBio will continue to invest in R&D and technology development, with a focus on advanced technology platforms and data-enabled manufacturing processes. The company noted that technology

More news about: AsymBio

Feb 10, 2026, 09:00 ET AsymBio crée des plates-formes technologiques intégrées couvrant l'ensemble du cycle de développement biopharmaceutique

plate-forme physico-chimique, la plate-forme de spectrométrie de masse et la plate-forme d'essais biologiques.AsymBio continuera d'investir dans la R&D et le développement technologique grâce à des plateformes technologiques avancées et à des processus de fabrication basés sur les données. En intégrant

More news about: AsymBio

Feb 10, 2026, 09:00 ET iCIMS Ranks No. 1 in User Experience for Enterprise Recruiting for Second Consecutive Year in Sapient Insights Group's HR Systems Survey Report

iCIMS STAR Awards. Global organizations such as The Container Store, ATCC, Expleo Group and H&R Block achieved measurable business impact, including 30% year-over-year headcount growth and 50% reduction in time to fill, using iCIMS.Access

More news about: iCIMS, Inc.

Feb 10, 2026, 09:00 ET Velo3D Qualified as First Additive Manufacturing Vendor for U.S. Army Ground Vehicles

Combat Capabilities Development Command (DEVCOM) Ground Vehicle Systems Center (GVSC), based at the Detroit Arsenal in Michigan, is the Army's primary R&D organization for ground vehicle technology, electrification, survivability and advanced manufacturing. GVSC develops and integrates next-generation

More news about: Velo3D, Inc.

Feb 10, 2026, 08:41 ET Proprietary Deep-Tech Integration Helps Spectral Capital's 42 Telecom Double January 2026 Revenues Year-Over-Year

enterprise value.About Spectral Capital CorporationSpectral Capital (OTCQB: FCCN) is a deep‑tech IP platform that integrates R&D, IP strategy and commercial operations to deliver scalable, high‑margin solutions. Anchored by profitable, cash‑generating digital infrastructure businesses,

More news about: Spectral Capital Corporation

Feb 10, 2026, 08:35 ET ObvioGo Now Integrated with Oracle Life Sciences Clinical One Data Collection

The integrated offering extends Oracle Health and Life Sciences Clinical R&D portfolio with ObvioGo's enterprise-grade ePRO, eConsent, and eCOA capabilities. This new direct integration enables sponsors and CROs to deploy participant-facing

More news about: ObvioHealth

Feb 10, 2026, 08:32 ET ACS and Siemens Deliver Integrated Motor Drive Solutions for Complex Aerospace and Industrial Applications

designed and engineered to work together. We combine our knowledge of building design and construction with expertise and understanding of equipment, R&D and production test, process systems, automation, data acquisition, and controls for industry leaders who require high-performance systems. ACS is

More news about: ACS

Feb 10, 2026, 08:32 ET The Anatomy of a Heartache: Celebrating Six Decades of Motown's Most Resilient Anthem and the Responsibility of Preserving Musical Legacy

there.Released in June 1966, "What Becomes of the Brokenhearted" quickly became one of Motown Records' defining successes—reaching No. 1 on the Billboard R&B Singles chart, cracking the Top 10 of the Billboard Hot 100 (peaking at No. 7), and standing as one of the label's most successful crossover records

More news about: Redemption Music Media

Feb 10, 2026, 08:31 ET First-Ever Standards and Ratings To Protect Teen Mental Health Online Launched Under the Leadership of The Mental Health Coalition

the need for bipartisan solutions to address the mental health impact of digital platforms on youth. Senators Mark Warner (D-VA) and Bernie Moreno (R-OH) expressed support for the S.O.S. initiative. In 2023, Surgeon General Dr. Vivek Murthy issued an

More news about: The Mental Health Coalition

Feb 10, 2026, 08:30 ET Novel Serotonergic Agonists Positioned to Capture Share of $150B+ Neuropsychiatric Market

global markets, building high-performance organizations, and creating long-term shareholder value. His career spans senior leadership roles across R&D, commercialization, corporate strategy, and capital formation, positioning him to lead Helus through its next phase of growth."I am honored

More news about: Market News Updates

Feb 10, 2026, 08:15 ET 100 Reasons to Celebrate: IXL Honors the Teachers Powering Today's Classrooms

grade level."Sometimes, the barrier to success isn't a lack of direction, but a language gap. Elite 100 recipient Javier Velazquez of Charles R. Drew Elementary School saw this firsthand. To help his English language learners bridge that divide, he uses IXL's multi-language support tools,

More news about: IXL Learning

Feb 10, 2026, 08:12 ET Living Proof Introduces Perfect hair Day™ Style Refresh Mist to Revolutionize Between-Wash Styling and Give Consumers Time Back

extending styles between washes and making it faster and easier to refresh and restyle dry hair without starting over," said Ron McLaughlin, Chief R&D Officer at Living Proof. "The formula works by resetting the hydrogen bonds that shape the hair, allowing you to smooth creases, revive your style,

More news about: Living Proof

Feb 10, 2026, 08:06 ET 제타바이트와 라이트온, 마이크로 엣지 AI 추론 인프라 공동 R&D 협력 발표

More news about: Zettabyte

Feb 10, 2026, 08:03 ET Kantor & Kantor, LLP Secures Fifth Circuit ERISA Victory Against UnitedHealthcare

multiple appeals, the family was forced to pay out of pocket to continue life-saving treatment.The family was represented by Founding Partners Glenn R. Kantor and Lisa S. Kantor, and Partner Peter S. Sessions of Kantor & Kantor, LLP, a nationally recognized law firm focusing on ERISA litigation and

More news about: Kantor & Kantor, LLP

Feb 10, 2026, 08:00 ET WearOptimo to Host Webinar on the Future of Wearables for Precision Health Monitoring

Dr. Douglas E. Williams, Ph.D. – Former EVP of R&D at Biogen and a leading figure in biopharmaceutical innovation, business building and effectively taking health products to market.

More news about: WearOptimo

Feb 10, 2026, 08:00 ET Tharros to Scale Federal Cybersecurity Solutions with Venture Capital Investment from Blue Delta Capital Partners

shifts."Tharros bridges the gap between high-level cyber research and real-world operations. By combining deep domain expertise with cutting-edge R&D, the company identifies zero-day vulnerabilities and hardens systems at the speed of the mission."Tharros stands out because they aren't just

More news about: Tharros

Feb 10, 2026, 08:00 ET Vesalio Expands International Neurovascular Portfolio with CE Mark of NeVa VS and NeVa 3.0 mm and Receives Additional FDA 510(k) Clearance for its Aspiration Catheters

[email protected]:1. Gupta R, Woodward K, Fiorella D, et al. Primary results of the Vesalio NeVa VS for the Treatment of Symptomatic Cerebral Vasospasm following Aneurysm Subarachnoid

More news about: Vesalio